Yemaachi Biotechnology

Active

Diversifying precision cancer diagnostics and treatments

What it does

Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access to the most genetically diverse population on the planet to build a first-of-its-kind clinical and molecular knowledgebase on cancer among African people.

Its site says now · captured 2026-08-23

Yemaachi Biotech – Cancer Innovation Shaped by Africa

Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in diverse populations.

Next to it in Healthcare and bio · precision cancer diagnostics Africa

  • Signatur BiosciencesY Combinator S22

    Simple tests for complex diseases.

  • AOA DxY Combinator S21

    Blood Test for Early Detection of Ovarian Cancer

  • NearWaveY Combinator W22

    Helping physicians select the right therapy for breast cancer patients

  • CrosscopeTechstars TS 2020

    Crosscope | Next Generation Pathology

  • NumenY Combinator S23

    Engineering a future without cancer deaths.

  • Data Driven BioscienceY Combinator S18

    Cancer Diagnosis 10X faster, 10X cheaper

  • Asima Health Inc.Plug and Play PnP 2024

    World's fastest, simplest and cheapest pan-cancer screening platform.

  • NeurodeSOSV SOSV HAX 2021

    Changing the way we treat ADHD